ANTI-NUCLEAR ANTIBODIES (ANA)

Purpose of test:
Screens for systemic lupus erythematosus
Screens for several autoimmune disorders
Monitors effectiveness of treatment with drugs for sysstemic lupus erythematosus

Patient preparation:
None required

Time before test results available:
* 4 to 5 days

Normal values:
Test for Ana is negative at a titer of 1:32 or below

What absence of ANA may indicate:
Rules out systemic lupus erythematosus

What low titers may indicate:
Viral diseases
Liver disease
Collagen-vascular disease
Autoimmune disease

Taking these drugs may affect test results:
Acetazolamide
Aminosalicylic acid (PAS)
Chlorothiazide
Chlorpromazine
Chlorprothixene
Clofibrate
Ethosuximide
Gold salts
Griseofulvin
Hydralazine
Isoniazid
Mephenytoin
Methyldopa
Methysergide
Oral contraceptives
Para-aminosaalicylic acid
Penicillin
Phenylbutazone
Phenytoin
Primidone
Procainamide
Propylthiouracil
Wuinidine
Reserpine
Streptomycin
Sulfonamides
Tetracyclines
Thiouracil
Trimethadion

Other factors that may affect test results:
If tourniquet is applied on the arm for too long (over 1 minute), it may cause an inaccurate test result. Request another sameple to be collected to ensure accuracy.

Advertisement

Hepatitis C Primer Home

What is Hepatitis How is Hepatitis Transmitted

Long-term Prognosis

Complications of HCV Liver Biopsy Treatment Info (Interferon, Herbal, etc) Lab Tests (PCR, Genotype,etc.) Nutrition & Alternative Info

Patient Information (Support Groups, Doctor Listing, etc) Related Webpages Transplant Info Site Search HCV Webrings Guestbook FAQ & Disclaimers

Who Will Respond to Hepatitis C Treatment
The relatively new field of proteomics may be able to predict who will respond to Hepatitis C therapy - before treatment even begins....

Antivirals Combined Without Interferon: New Trial
Three companies unite to begin an innovative Hepatitis C trial, where two oral antiviral drugs will be combined in the absence of interferon....

HCV May Be Able to Be Cleared from Both Blood and Liver
Viral clearance doubled in a Hepatitis C Phase II trial during standard therapy when coupled with GlobeImmune's GI-5005. Because Hepatitis C must be eradicated not just from the blood, but also the liver, GI-5005's ability to speed the clearance rate...

More Hep C articles ...